HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Andrew J Lees Selected Research

Dopamine Agents (Dopaminergic Agents)

2/2013Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease.
11/2011Testing an aetiological model of visual hallucinations in Parkinson's disease.
4/2010Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study.
4/2008Managing Parkinson's disease with continuous dopaminergic stimulation.
5/2006Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
9/2002Treatment of Parkinson's disease: levodopa as the first choice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Andrew J Lees Research Topics

Disease

76Parkinson Disease (Parkinson's Disease)
12/2015 - 09/2002
32Parkinsonian Disorders (Parkinsonism)
01/2015 - 10/2002
15Dyskinesias (Dyskinesia)
01/2015 - 09/2002
12Dementia (Dementias)
01/2015 - 09/2003
11Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
06/2014 - 07/2003
8Tremor (Tremors)
01/2015 - 04/2003
8Dystonia (Limb Dystonia)
10/2012 - 12/2002
5Impulse Control Disorders (Kleptomania)
12/2015 - 09/2009
5Multiple System Atrophy
06/2015 - 09/2009
5Hypokinesia (Bradykinesia)
01/2015 - 03/2003
5Neurodegenerative Diseases (Neurodegenerative Disease)
05/2013 - 10/2005
5Gambling (Pathological Gambling)
11/2011 - 09/2007
4Alzheimer Disease (Alzheimer's Disease)
09/2009 - 07/2003
3Hallucinations (Hallucination)
01/2015 - 09/2002
3Tauopathies
11/2012 - 04/2004
3Bulimia (Binge Eating)
11/2011 - 04/2010
3Frontotemporal Lobar Degeneration (Semantic Dementia)
11/2011 - 09/2009
3Paralysis (Palsy)
09/2010 - 03/2003
2Frontotemporal Dementia
01/2015 - 10/2006
2Disease Progression
01/2014 - 04/2008
2Movement Disorders (Movement Disorder)
08/2012 - 11/2010
2Bipolar Disorder (Mania)
06/2011 - 04/2004
2Pain (Aches)
06/2009 - 03/2004
2Dysarthria (Spastic Dysarthria)
08/2005 - 09/2002
2Dystonic Disorders (Writer's Cramp)
04/2005 - 06/2003
1Orthostatic Hypotension (Postural Hypotension)
01/2015
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
08/2014
1Fibromyalgia (Fibrositis)
08/2014
1Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
08/2014
1Diarrhea
01/2014
1Nausea
01/2014
1Chronic Brain Injury (Chronic Traumatic Encephalopathy)
01/2014
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
04/2013
1Gaucher Disease (Gaucher's Disease)
02/2013
1Craniocerebral Trauma (Head Injury)
12/2012
1Stomach Ulcer (Gastric Ulcer)
12/2012
1Diabetes Mellitus
12/2012
1Hypertension (High Blood Pressure)
12/2012
1Mouth Neoplasms (Oral Cancer)
12/2012
1Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
11/2012
1Lewy Body Disease (Lewy Body Dementia)
06/2012
1Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile)
04/2012
1Muscular Diseases (Myopathy)
03/2012

Drug/Important Bio-Agent (IBA)

39Levodopa (L Dopa)FDA LinkGeneric
01/2015 - 09/2002
25Dopamine (Intropin)FDA LinkGeneric
12/2015 - 10/2002
12Dopamine Agonists (Dopamine Agonist)IBA
01/2014 - 09/2002
7SynucleinsIBA
06/2015 - 09/2007
6Dopamine Agents (Dopaminergic Agents)IBA
02/2013 - 09/2002
6alpha-SynucleinIBA
11/2010 - 02/2004
5UbiquitinIBA
09/2011 - 07/2003
52- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
11/2010 - 12/2002
5Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
04/2010 - 10/2004
5ApomorphineIBA
01/2009 - 09/2002
4RacloprideIBA
06/2015 - 06/2004
4Amyloid (Amyloid Fibrils)IBA
01/2014 - 04/2008
4Protein Isoforms (Isoforms)IBA
11/2012 - 02/2004
4Dihydroxyphenylalanine (Dopa)IBA
10/2012 - 10/2002
4Leucine (L-Leucine)FDA Link
09/2012 - 01/2005
4Phosphotransferases (Kinase)IBA
09/2012 - 01/2005
3Biological Markers (Surrogate Marker)IBA
10/2014 - 11/2010
3protein TDP-43 (TDP-43)IBA
08/2014 - 09/2009
3tau Proteins (tau Protein)IBA
06/2014 - 09/2003
3Proteins (Proteins, Gene)IBA
01/2014 - 11/2005
3Glucosylceramidase (Glucocerebrosidase)IBA
02/2013 - 06/2009
3AntibodiesIBA
11/2012 - 10/2004
3fluorodopa F 18IBA
11/2009 - 09/2005
2tolcapone (Tasmar)FDA Link
01/2014 - 01/2008
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
08/2013 - 01/2008
2CamptocormiaIBA
08/2012 - 03/2012
2Carbon MonoxideIBA
09/2011 - 08/2011
2RNA (Ribonucleic Acid)IBA
08/2011 - 01/2004
2Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
04/2011 - 06/2006
2Dopa-responsive DystoniaIBA
04/2011 - 06/2003
2IronIBA
09/2010 - 06/2010
2Proteasome Endopeptidase Complex (Proteasome)IBA
07/2010 - 04/2004
2pregnancy-associated growth factorIBA
05/2008 - 06/2007
2Dopamine Receptors (Dopamine Receptor)IBA
04/2008 - 02/2005
2entacapone (Comtan)FDA Link
01/2008 - 09/2004
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
05/2007 - 08/2003
2Messenger RNA (mRNA)IBA
10/2006 - 02/2004
1neuromelaninIBA
01/2015
1EnzymesIBA
01/2014
1Hunt's syndromeIBA
04/2013
1monomethylpropion (methcathinone)IBA
04/2013
1CoffeeFDA Link
12/2012
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
12/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2012
1Acetaminophen (Paracetamol)FDA LinkGeneric
12/2012
1TeaIBA
12/2012
1NicotineFDA Link
11/2012
1donepezil (Aricept)FDA LinkGeneric
09/2012
1Mitochondrial DNA (mtDNA)IBA
06/2012
1Phospholipases A2 (Phospholipase A2)IBA
04/2012
1Neurodegeneration with brain iron accumulation (NBIA)IBA
04/2012
1pantothenate kinaseIBA
04/2012

Therapy/Procedure

3Deep Brain Stimulation
01/2014 - 09/2009
3Drug Therapy (Chemotherapy)
08/2011 - 05/2010
2Denervation
02/2010 - 03/2003
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
12/2012
1General Anesthesia
12/2012